HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katharina Seystahl Selected Research

enzastaurin

5/2012Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katharina Seystahl Research Topics

Disease

14Glioblastoma (Glioblastoma Multiforme)
02/2022 - 05/2012
12Neoplasms (Cancer)
02/2022 - 01/2012
8Glioma (Gliomas)
06/2021 - 01/2013
3Meningioma (Meningiomas)
01/2019 - 03/2016
2Venous Thromboembolism
01/2022 - 11/2021
2Necrosis
04/2021 - 01/2016
2Hemangioblastoma
01/2014 - 01/2012
1Brain Neoplasms (Brain Tumor)
01/2022
1Edema (Dropsy)
03/2016
1Brain Edema (Cerebral Edema)
03/2016
1Hypoxia (Hypoxemia)
02/2015
1Cysts
02/2014
1Lymphoma (Lymphomas)
09/2012
1Leukemia
09/2012

Drug/Important Bio-Agent (IBA)

7Bevacizumab (Avastin)FDA Link
03/2020 - 01/2012
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2021 - 01/2012
4Biomarkers (Surrogate Marker)IBA
11/2016 - 02/2015
3Transforming Growth Factors (Transforming Growth Factor)IBA
01/2017 - 02/2015
3Biological ProductsIBA
01/2017 - 01/2016
2Irinotecan (Camptosar)FDA LinkGeneric
03/2020 - 01/2013
2Temozolomide (Temodar)FDA LinkGeneric
06/2016 - 01/2013
2cediranib (AZD2171)IBA
01/2016 - 05/2012
1Oxygen (Dioxygen)IBA
02/2022
1Carbon DioxideIBA
02/2022
1vinyltriethoxysilane (VTES)IBA
01/2022
1AnticoagulantsIBA
01/2022
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2022
1C-Reactive ProteinIBA
11/2021
1Hemoglobins (Hemoglobin)IBA
11/2021
1EndoglinIBA
06/2021
1LigandsIBA
06/2021
1Alkylating AgentsIBA
03/2020
1thiamine triphosphorate (TTP)IBA
01/2020
1Plasminogen InactivatorsIBA
01/2017
1Protein Isoforms (Isoforms)IBA
01/2017
1Antisense OligonucleotidesIBA
01/2017
1Messenger RNA (mRNA)IBA
01/2017
1LY-2157299IBA
12/2016
1Radioisotopes (Radionuclides)IBA
11/2016
1Somatostatin Receptors (Somatostatin Receptor)IBA
11/2016
1Edotreotide (SMT 487)IBA
11/2016
1Antineoplastic Agents (Antineoplastics)IBA
03/2016
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2016
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2016
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2016
1Tyrosine Kinase InhibitorsIBA
01/2016
1Neutralizing AntibodiesIBA
01/2016
1Lomustine (CCNU)FDA Link
10/2014
1Dasatinib (BMS 354825)FDA Link
09/2012
1CytokinesIBA
09/2012
1afliberceptIBA
05/2012
1Angiogenesis InhibitorsIBA
05/2012
1enzastaurinIBA
05/2012

Therapy/Procedure

4Radiotherapy
04/2021 - 01/2013
4Drug Therapy (Chemotherapy)
03/2020 - 01/2013
4Therapeutics
11/2016 - 01/2014
2Aftercare (After-Treatment)
01/2019 - 01/2012
1Chemoradiotherapy
01/2022
1Terminal Care (Care, Terminal)
05/2020
1Immunotherapy
03/2016
1Ventriculostomy
02/2014